CVE-2025-43744

Description

A stored DOM-based Cross-Site Scripting (XSS) vulnerability in Liferay Portal 7.4.0 through 7.4.3.132, and Liferay DXP 2025.Q2.0 through 2025.Q2.5, 2025.Q1.0 through 2025.Q1.15, 2024.Q4.0 through 2024.Q4.7, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.19 and 7.4 GA through update 92 exists in the Asset Publisher configuration UI within the Source.js module. This vulnerability allows attackers to inject arbitrary JavaScript via DDM structure field labels which are then inserted into the DOM using innerHTML without proper encoding.

References

Link	Tags
https://liferay.dev/portal/security/known-vulnerabilities/-/asset_publisher/jekt/content/CVE-2025-43744

Frequently Asked Questions

What is the severity of CVE-2025-43744?: CVE-2025-43744 has been scored as a medium severity vulnerability.
How to fix CVE-2025-43744?: To fix CVE-2025-43744, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-43744 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2025-43744 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-43744?: CVE-2025-43744 affects Liferay Portal, Liferay DXP.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.

Description

Category

CWE-79 – Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

References

Frequently Asked Questions